http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2008002025-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2008-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b55d3d533f4be1633774f247aa8f992e
publicationDate 2009-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2008002025-A1
titleOfInvention Oral pharmaceutical solution comprising telbivudine, sodium saccharin, a soluble flavor, benzoic acid and a citrate buffer, useful for the treatment of hepatitis B in the pediatric population, in people with swallowing difficulties and in renally impaired subjects.
abstract Oral pharmaceutical solutions comprising telbivudine intended for the treatment of hepatitis B in the pediatric population, in people with swallowing difficulties and in renally impaired subjects.
priorityDate 2007-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159269

Total number of triples: 22.